Taming hemodialysis-induced inflammation : Are complement C3 inhibitors a viable option?
Published by Elsevier Inc.
Publié dans: | Clinical immunology (Orlando, Fla.). - 1999. - 198(2019) vom: 01. Jan., Seite 102-105 |
---|---|
Auteur principal: | |
Autres auteurs: | , , , , , , , |
Format: | Article en ligne |
Langue: | English |
Publié: |
2019
|
Accès à la collection: | Clinical immunology (Orlando, Fla.) |
Sujets: | Journal Article Research Support, N.I.H., Extramural AMY-101 Complement C3 Compstatins Cp40 Hemodialysis Thromboinflammation Complement Inactivating Agents |
Accès en ligne |
Volltext |